Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?
作者信息
Dünser Martin W, Meier Jens
机构信息
Department of Critical Care, University College of London Hospital, London, UK.
Department of Anesthesiology and Intensive Care Medicine, Kepler University Hospital, Linz, Austria.
出版信息
J Thorac Dis. 2017 Jul;9(7):1843-1847. doi: 10.21037/jtd.2017.06.127.
Abstract
摘要
相似文献
1
Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?休克中的血管加压素——去甲肾上腺素、血管升压素或血管紧张素II：哪一种会胜出？
J Thorac Dis. 2017 Jul;9(7):1843-1847. doi: 10.21037/jtd.2017.06.127.
2
Vasopressor therapy in critically ill patients with shock.血管加压素治疗休克危重症患者。
Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23.
3
Vasopressor Therapy in the Intensive Care Unit.重症监护病房中的血管加压药治疗
Semin Respir Crit Care Med. 2021 Feb;42(1):59-77. doi: 10.1055/s-0040-1710320. Epub 2020 Aug 20.
4
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review.难治性感染性休克中的血管紧张素 II 治疗：哪些患者获益最大？一篇叙述性综述。
J Anesth Analg Crit Care. 2024 Feb 21;4(1):13. doi: 10.1186/s44158-024-00150-w.
5
The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.DPP3、血管紧张素 II 和脓毒症中的肾素动力学（DARK-Sepsis）随机对照试验的科学原理和研究方案：血清生物标志物预测血管紧张素 II 与标准升压治疗对脓毒性休克治疗反应的比较。
Trials. 2024 Mar 12;25(1):182. doi: 10.1186/s13063-024-07995-0.
6
The Role of Angiotensin II in Poisoning-Induced Shock-a Review.血管紧张素 II 在中毒性休克中的作用——综述。
J Med Toxicol. 2022 Apr;18(2):145-154. doi: 10.1007/s13181-022-00885-4. Epub 2022 Mar 8.
7
Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.皮质类固醇对脓毒性休克患者使用含精氨酸加压素血管升压药治疗的影响：一项病例对照研究。
J Crit Care. 2008 Dec;23(4):500-6. doi: 10.1016/j.jcrc.2008.04.002. Epub 2008 Jun 30.
8
Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.血管紧张素 II 输注治疗休克：上市后使用的多中心研究。
Chest. 2021 Feb;159(2):596-605. doi: 10.1016/j.chest.2020.08.2074. Epub 2020 Aug 31.
9
Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU.血管紧张素II对儿茶酚胺难治性脓毒性或分布性休克死亡率的影响：医学重症监护病房真实世界经验的倾向评分加权分析
Crit Care Explor. 2022 Jan 18;4(1):e0623. doi: 10.1097/CCE.0000000000000623. eCollection 2022 Jan.
10
Noradrenaline, vasopressin and angiotensin increase Ca2+ influx by opening a common pool of Ca2+ channels in isolated rat liver cells.去甲肾上腺素、血管加压素和血管紧张素通过打开分离的大鼠肝细胞中一个共同的钙离子通道池来增加钙离子内流。
Biochem J. 1984 Jul 1;221(1):121-7. doi: 10.1042/bj2210121.
引用本文的文献
1
Angiotensin II in Catecholamine-Refractory Shock: A Systematic Review and Exploratory Analysis of the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Trial.儿茶酚胺难治性休克中的血管紧张素II：血管紧张素II治疗高输出量休克（ATHOS-3）试验的系统评价与探索性分析
Cureus. 2025 Jun 22;17(6):e86546. doi: 10.7759/cureus.86546. eCollection 2025 Jun.
本文引用的文献
1
Angiotensin II for the Treatment of Vasodilatory Shock.血管紧张素 II 用于治疗血管舒张性休克。
N Engl J Med. 2017 Dec 28;377(26):2604. doi: 10.1056/NEJMc1714511.
2
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.血管舒张性休克患者或有血管舒张性休克风险患者使用非肾上腺素能血管升压药。一项随机试验的系统评价和荟萃分析
PLoS One. 2015 Nov 11;10(11):e0142605. doi: 10.1371/journal.pone.0142605. eCollection 2015.
3
Angiotensin II: a new approach for refractory shock management?血管紧张素II：难治性休克治疗的新方法？
Crit Care. 2014 Dec 18;18(6):694. doi: 10.1186/s13054-014-0694-7.
4
Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.静脉输注血管紧张素II治疗高输出量休克（ATHOS试验）：一项试点研究。
Crit Care. 2014 Oct 6;18(5):534. doi: 10.1186/s13054-014-0534-9.
5
Interference of angiotensin II and enalapril with hepatic blood flow regulation.血管紧张素 II 和依那普利对肝血流量调节的干扰。
Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G655-63. doi: 10.1152/ajpgi.00150.2014. Epub 2014 Jul 24.
6
Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis.脓毒性休克中的血管紧张素II：对猪粪便性腹膜炎模型中组织灌注、器官功能和线粒体呼吸的影响
Crit Care Med. 2014 Aug;42(8):e550-9. doi: 10.1097/CCM.0000000000000397.
7
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.儿茶酚胺血管加压素治疗期间的心脏不良事件：一项前瞻性观察研究。
Intensive Care Med. 2012 Jun;38(6):950-8. doi: 10.1007/s00134-012-2531-2. Epub 2012 Apr 12.
8
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.严重脓毒症住院患者新发心房颤动与中风和死亡事件相关。
JAMA. 2011 Nov 23;306(20):2248-54. doi: 10.1001/jama.2011.1615. Epub 2011 Nov 13.
9
Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey.目前欧洲重症监护病房感染性休克患者血流动力学管理方法：一项基于横断面、自我报告的问卷调查研究。
Eur J Anaesthesiol. 2011 Apr;28(4):284-90. doi: 10.1097/EJA.0b013e3283405062.
10
Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress.危重病期间的交感神经过度刺激：肾上腺素能应激的不良效应。
J Intensive Care Med. 2009 Sep-Oct;24(5):293-316. doi: 10.1177/0885066609340519. Epub 2009 Aug 23.
Zotero 插件